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of JNK in glomerular mesangial cells
MOTOHIDE ISONO, MASAKAZU HANEDA, SHIRO MAEDA, MARIKO OMATSU-KANBE, and RYUICHI KIKKAWA
The Third Department of Medicine and Department of Physiology, Shiga University of Medical Science, Shiga, Japan
Atrial natriuretic peptide inhibits endothelin-1-induced activation of
JNK in glomerular mesangial cells. Atrial natriuretic peptide (ANP) has
been shown to counteract various actions of endothelin-1 (ET-1) in
mesangial cells. We have reported that both extracellular signal-regulated
kinase (ERK) and c-Jun NH2-terminal kinase (JNK) are activated by ET-1
and ET-1-induced activation of ERK is inhibited by ANP. To further
clarify the action of ANP, we examined the effect of ANP on ET-1-
induced activation of JNK. ANP inhibited ET-1-induced activation of JNK
in a dose-dependent manner. This inhibitory effect of ANP was reversed
by HS-142-1, an antagonist for biological receptors of ANP, while C-ANP,
an analog specific to clearance receptors of ANP, failed to inhibit
ET-1-induced activation of JNK. 8-Bromo-cGMP and sodium nitroprus-
side were also able to inhibit ET-1-induced activation of JNK, suggesting
cGMP-dependent action of ANP. In contrast, ANP failed to inhibit
interleukin-1b (IL-1b)-induced activation of JNK. Since an increase in
intracellular calcium ([Ca21]i) was shown to be necessary for ET-1-
induced activation of JNK in mesangial cells, we measured [Ca21]i using
fura-2. ANP attenuated the ET-1-induced increase in [Ca21]i in concen-
trations enough to inhibit ET-1-induced activation of JNK. Finally, ANP
was able to inhibit ET-1-, but not IL-1b-induced increase in DNA-binding
activity of AP-1 by gel shift assay. These results indicate that ANP is able
to inhibit ET-1-induced activation of AP-1 by inhibiting both ERK and
JNK, suggesting that ANP might be able to counteract the expression of
AP-1-dependent genes induced by ET-1.
Endothelin-1 (ET-1), one of the potent vasoconstrictive pep-
tides, is known to contribute to the regulation of glomerular
filtration rate by inducing the contraction of glomerular mesangial
cells [1]. In addition, ET-1 has been shown to induce the
proliferation and extracellular matrix (ECM) protein production
in mesangial cells [2–5]. In contrast, atrial natriuretic peptide
(ANP), one of the vasorelaxing substances, has been found not
only to induce the relaxation of mesangial cells, but also to
counteract the contraction, proliferation, and ECM protein pro-
duction induced by ET-1 [6–9]. Therefore, the interaction be-
tween vasoconstrictive and vasorelaxing substances is considered
to be important in the regulation of various functions of glomer-
ular mesangial cells. However, the mechanisms of the interaction
between these substances are not fully elucidated yet.
Recently, the mitogen-activated protein kinase (MAPK) family,
including extracellular signal-regulated kinase (ERK), c-Jun NH2-
terminal kinase (JNK) and p38 MAP kinase, was identified in
mammalian cells [10]. These kinases were shown to be activated in
response to diverse extracellular stimuli including vasoconstrictive
peptides [11–15], and thus play a key role in the signal transduc-
tion leading to various cellular functions such as contraction,
proliferation and protein synthesis [13–17]. We and others have
reported that ET-1 is able to activate ERK in mesangial cells [11,
12, 18], and we have recently reported that JNK is also activated
by ET-1 in mesangial cells [19]. Activation of both ERK and JNK
is considered to induce the phosphorylation of several transcrip-
tion factors such as Elk-1, c-Jun, ATF-2 [16, 20, 21], resulting in
the formation of the AP-1 complex [22]. Indeed, we and others
have reported that ET-1 enhances the DNA-binding activity of
AP-1 in mesangial cells [19, 23], indicating that the activation
of both ERK and JNK by ET-1 might contribute to the regulation
of the expression of a number of genes through the activation of
AP-1.
From these observations, we hypothesized that ANP could
counteract the effect of ET-1 by inhibiting the ET-1-induced
activation of the MAPK family in mesangial cells. In fact, we
found that ANP was able to inhibit ET-1-induced activation of
ERK in cultured rat mesangial cells [18, 24]. To further clarify the
action of ANP, in the present study we examined whether ANP
could inhibit the ET-1-induced activation of JNK and the ET-1-
induced increase in DNA-binding activity of AP-1 in mesangial
cells.
METHODS
Materials
Rat ET-1 and ANP were obtained from Peptide Institute (Osaka,
Japan). 8-Bromo-cGMP (8-Br-cGMP), sodium nitroprusside (SNP)
and rat des-[Glu18-Ser19-Gly20-Leu21-Gly22]ANP4-23-NH2 (C-
ANP) were purchased from Sigma (St. Louis, MO, USA). HS-142-1
was kindly supplied by Kyowa Hakko Kogyo (Tokyo, Japan). The
glutathione-S-transferase (GST) fusion protein expression vector
containing the transactivation domain of c-Jun (amino acids 1 to
79), pGEX2T-c-Jun, was a gift of Dr. Michael Karin (University
of California, San Diego, CA, USA). Glutathione Sepharose 4B
was purchased from Pharmacia Biotechnology (Uppsala, Swe-
den). Recombinant human interleukin 1b (IL-1b) was purchased
from Genzyme (Cambridge, MA, USA). [g-32P]ATP (6000 Ci/
mmol) was bought from NEN Research Products (Boston, MA,
USA). Anti-ACTIVEy-JNK antibody and anti-JNK1 antibody
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were purchased from Promega (Madison, WI, USA) and Santa
Cruz Biotechnology (Santa Cruz, CA, USA), respectively. Fura-2
acetoxymethylester (fura-2/AM) was obtained from Dojin Chem-
icals (Kumamoto, Japan). All other reagents were of chemical
grade and purchased from standard suppliers.
Mesangial cell culture and experimental protocol
Glomerular mesangial cells were obtained from a culture of
glomeruli isolated from male Sprague-Dawley rats weighing 100
to 150 g by a sieving method as previously described [25]. Isolated
glomeruli were cultured in the RPMI 1640 medium containing
20% heat-inactivated fetal bovine serum (FBS), 100 units/ml
penicillin, 100 mg/ml streptomycin, 5 mg/ml insulin, 5 mg/ml
transferrin and 5 ng/ml selenious acid. Cultured cells were iden-
tified as mesangial cells by morphological and biochemical char-
acters as previously described [26].
Subconfluent cells were made quiescent by reducing the con-
centrations of FBS to 0.4% for 24 hours. Quiescent mesangial
cells were incubated in an incubation medium (RPMI 1640
medium with 0.4% fatty acid free bovine serum albumin and 20
mM Hepes, pH 7.4) at 37°C for 30 minutes. Cells were first
exposed to ANP or intracellular cGMP-raising agents for 10
minutes and then to ET-1 or IL-1b for another 15 minutes. The
reactions were terminated by a rapid aspiration of medium and
washing twice with ice-cold phosphate buffered saline (PBS) on
ice.
Preparation of GST-c-Jun
The GST fusion protein expression vector, pGEX2T-c-Jun, was
introduced into E. coli. The bacterial lysates containing the fusion
protein were incubated with glutathione Sepharose 4B and GST-
c-Jun (1-79) fusion protein bound to glutathione sepharose beads
was collected by centrifugation. The purity and amounts of
purified proteins were estimated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and subsequent
staining with Coomassie blue.
Measurement of the activities of JNK
The cells were lysed in a buffer containing 25 mM Hepes, pH
7.5, 0.3 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM dithio-
threitol (DTT), 20 mM b-glycerophosphate, 1 mM vanadate, 0.1%
Triton X-100, 1 mM phenylmethylsulfonyl fluoride (PMSF), 20
mg/ml aprotinin, and 20 mg/ml leupeptin. The cell lysates were
centrifuged at 12,000 g for 30 minutes and the supernatants were
used for JNK assay. The concentrations of cellular protein were
determined using protein assay kit (BioRad Laboratories, CA,
USA).
The activities of JNK were measured by the solid-phase kinase
assay [27] because we confirmed that the kinases bound to
GST-c-Jun (1-79) in this assay were 46 and 54 kDa JNK [19]. For
the solid-phase kinase assay, cell lysates were incubated with
GST-c-Jun (1-79) fusion protein bound to glutathione-sepharose
Fig. 1. Atrial natriuretic peptide (ANP)
inhibits endothelin-1 (ET-1)-induced activation
of c-Jun NH2-terminal kinase (JNK) in
mesangial cells. Quiescent mesangial cells were
treated with various concentrations of ANP for
10 minutes and then exposed to 1028 M ET-1
for another 15 minutes. Cell lysates were
incubated with GST-c-Jun bound to glutathione
sepharose beads and kinase reactions were
performed on the beads (solid phase kinase
assay). A representative autoradiograph (A)
and the relative kinase activities of JNK (B) are
shown. Values are mean 6 SD (N 5 5). *P ,
0.01 versus basal (without ET-1), #P , 0.05
versus ET-1.
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beads at 4°C for three hours. The beads were recovered by
centrifugation at 10,000 g for 10 seconds and then washed three
times with a buffer containing 20 mM Hepes, pH 7.7, 50 mM NaCl,
2.5 mM MgCl2, 0.1 mM EDTA and 0.05% Triton X-100, and once
with a kinase buffer (20 mM Hepes, pH 7.6, 20 mM MgCl2, 20 mM
b-glycerophosphate, 20 mM p-nitrophenyl phosphate, 0.1 mM
vanadate, 2 mM DTT). The beads were then incubated with 30 ml
of a kinase buffer containing 20 mM unlabeled ATP and 5 mCi
[g-32P]ATP at 30°C for 20 minutes. The reaction was terminated
by the addition of 30 ml of 3 3 Laemmli sample buffer and boiling
at 100°C for five minutes. Phosphorylated proteins were resolved
on 12% SDS-PAGE, followed by an autoradiography. The rela-
tive kinase activities were quantified by the densitometolic anal-
ysis of autoradiographs.
Immunoblot analysis
The cells were lysed in 100 ml of SDS sample buffer (62.5 mM
Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 50 mM DTT, 0.1%
bromphenol blue) and sonicated for five seconds. After boiling for
five minutes, the samples were subjected to 12% SDS-polyacryl-
amide gels and electrotransferred to immobilon P membrane
(Millipore, Bedford, MA, USA). The membrane was probed with
anti-ACTIVEy-JNK antibody (diluted at 1:5000) at room tem-
perature for three hours. A horseradish peroxidase-conjugated
secondary antibody (1:1000) was used to allow the detection of
immunoreactive bands using the enhanced chemiluminescence
detection system (Amersham, Buckinghamshire, UK). The mem-
brane was then reprobed with anti-JNK1 antibody (1:500).
Measurement of intracellular calcium concentration
The concentrations of intracellular calcium ([Ca21]i) were
measured in a single cultured mesangial cell using Ca21-sensitive
fluorescent dye, fura-2 [28]. Krebs-Henseleit Hepes (KHH) buffer
(130 mM NaCl, 5 mM KCl, 1.25 mM CaCl2, 0.8 mM MgSO4, 20 mM
Hepes pH 7.4, 5.5 mM glucose, 0.1% FFA-free BSA) was used as
a standard solution. Mesangial cells plated on a glass cover slip
were loaded with 5 mM fura-2/AM for 40 minutes at 37°C in
serum-free RPMI 1640. After rinsing twice, cells were incubated
for 20 minutes at 37°C in serum-free RPMI 1640. Then, the cover
slip was transferred into a chamber placed on the stage of an
inverted microscope (Nikon, Diaphot-TMD, Tokyo, Japan). The
solution and the chamber were kept at 37°C in a water bath.
Measurements were performed using a microspectrofluorometer
(Nihon Bunko, CAM-200, Tokyo, Japan). The excitation and
emission wavelength were 340/380 nm and 510 nm, respectively.
The ratio of the intensity of fluorescence excited at 340 nm to that
at 380 nm (ratio F340/F380) was used as an indicator of [Ca
21]i.
The following equation by Grynkiewicz, Poenie and Tsien [28] was
Fig. 2. Effect of HS-142-1 or C-ANP on the
activation of JNK activation. Cells were treated
with vehicle (lane 1 to 3, 5) or 1 mg/ml HS-142-
1 (lane 4) for 10 minutes, with 1027 M ANP
(lane 3, 4) or 1027 M C-ANP (lane 5) for
additional 10 minutes and exposed to 1028 M
ET-1 (lanes 2 to 5) for 15 minutes. The
activities of JNK were measured by the solid
phase kinase assay. A representative
autoradiograph (A) and the relative kinase
activities of JNK (B) are shown. Values are
mean 6 SD (N 5 3). *P , 0.05 versus basal
(lane 1), #P , 0.05 versus ET-1 (lane 2), $P ,
0.05 versus ET1ANP (lane 3).
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adopted for conversion to the fluorescence ratio into intracellular
calcium: [Ca21]i 5 (R 2 Rmin)/(Rmax 2 R) 3 Kd 3 (F380 min/
F380 max), where R is the ratio F340/380 measured, Rmin and Rmax is R
when the calcium concentration is minimum (incubated with the
calcium- and magnesium-free KHH buffer containing 5 mM
EGTA and 5 mM ionomycin) and maximum (incubated with the
KHH buffer containing 5 mM ionomycin), respectively. Kd for the
fura-2 and calcium complex is 224 nM at 37°C [28].
Assessment of DNA-binding activity of AP-1
Nuclear extracts were prepared as described by Sadowski and
Gilman with modifications [29]. In brief, cells were lysed by the
addition of hypotonic buffer (20 mM Hepes, pH 7.9, 1 mM EGTA,
1 mM EDTA, 20 mM NaF, 1 mM Na3VO4, 1 mM Na4P2O7, 1 mM
DTT, 0.5 mM PMSF, 1 mg/ml aprotinin, 1 mg/ml leupeptin and 1
mg/ml pepstatin) with 0.6% Nonidet P-40, and lysates were
centrifuged at 16,000 g for 20 seconds. The pellets were resus-
pended in high salt buffer (hypotonic buffer with 420 mM NaCl
and 20% glycerol), rotated for 30 minutes at 4°C and centrifuged
at 16,000 g for 20 minutes. The supernatants were used as nuclear
proteins for a gel mobility shift assay. The nuclear proteins (5 mg)
were incubated with 2 mg of poly(dI-dC) z poly(dI-dC) in a binding
buffer (20 mM Hepes, pH 7.9, 1.8 mM MgCl2, 2 mM DTT, 0.5 mM
EDTA, 0.5 mg/ml BSA) for 30 minutes and then reacted with a
radiolabeled AP-1 consensus oligonucleotide at room tempera-
ture for 20 minutes. The reaction mixtures were run on 4%
polyacrylamide gel and autoradiographed.
Statistical analysis
Analysis of variance (ANOVA) followed by Scheffe´’s test was
used to determine significant difference in multiple comparisons.
Comparisons between two groups were analyzed by Student’s
unpaired t-test.
RESULTS
Effect of atrial natriuretic peptide on endothelin-1-induced
activation of JNK
Endothelin-1 was able to activate JNK in a dose-dependent
(1028 M maximum) and time-dependent manner, with a peak
stimulation at 15 minutes, in mesangial cells [19]. Thus, we
stimulated the cells with 1028 M ET-1 for 15 minutes. Cells were
first exposed to various concentrations of ANP for 10 minutes and
then to ET-1 (1028 M) for an additional 15 minutes. As shown in
Figure 1, ANP inhibited ET-1-induced activation of JNK in a
dose-dependent manner.
Mesangial cells were shown to have two types of receptors for
ANP, biological and clearance receptors [30]. In order to clarify
Fig. 3. Inhibitory effects of 8-Bromo-cGMP (8-Br-cGMP) and sodium nitroprusside (SNP) on endothelin-1 (ET-1)-induced activation of c-Jun
NH2-terminal kinase (JNK). Cells were treated with 10
23 M 8-Br-cGMP (A and B) or 1024 M SNP (C and D) for 10 minutes and exposed to 1028 M
ET-1 for additional 15 minutes. The activities of JNK were measured by the solid phase kinase assay. A representative autoradiograph (A, C) and the
relative kinase activities of JNK (B, D) are shown. Values are mean 6 SD (N 5 4 to 5). *P , 0.01 versus basal and 8-Br-cGMP or SNP, #P , 0.01 versus
ET-1.
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the receptors responsible for the inhibitory effect of ANP on the
ET-1-induced activation of JNK, we examined the effect of
HS-142-1, a competitive and selective antagonist for biological
receptors of ANP [31, 32], and C-ANP, an analog specific to
clearance receptors of ANP. The inhibitory effect of ANP on
ET-1-induced activation of JNK was significantly reduced by
treating the cells with HS-142-1 (1 mg/ml) for 10 minutes prior to
the addition of ANP (Fig. 2). C-ANP (1027 M) failed to inhibit
ET-1-induced activation of JNK (Fig. 2).
Effect of intracellular cGMP-raising agents on endothelin-1-
induced activation of JNK
Atrial natriuretic peptide is known to activate particulate
guanylyl cyclase and to increase intracellular cGMP after binding
to biological receptors in cultured rat mesangial cells, and cGMP
has been proposed as a second messenger for ANP [32, 33]. To
clarify whether the inhibitory effect of ANP on ET-1-induced
activation of JNK was mediated by an increase in intracellular
cGMP, we examined the effects of intracellular cGMP-raising
agents on ET-1-induced activation of JNK. Both 8-Br-cGMP, a
cell permeable analog of cGMP (Fig. 3 A, B), and SNP, an
activator of soluble guanylyl cyclase (Fig. 3 C, D), were able to
inhibit ET-1-induced activation of JNK, indicating that the inhib-
itory effect of ANP on ET-1-induced activation of JNK could be
mediated by cGMP-dependent mechanism through the biological
receptors.
Effect of atrial natriuretic peptide on interleukin 1b-induced
activation of JNK
JNK was first found to be activated in response to environmen-
tal stress such as UV irradiation and osmotic shock, and to
inflammatory cytokines such as interleukin 1b (IL-1b) and tumor
necrosis factor a (TNF-a) in various types of cells [34–38].
Recently, IL-1b has been shown to activate JNK in rat and human
mesangial cells [39, 40]. Therefore, we next examined the effect of
ANP on IL-1b-induced activation of JNK in mesangial cells. As
shown in Figure 4, IL-1b was able to activate JNK in a dose-
dependent manner with a maximum stimulation at 5000 pg/ml. In
contrast to ET-1-induced activation of JNK, ANP failed to inhibit
the activation of JNK induced by either maximum (5000 pg/ml) or
half-maximum (1000 pg/ml) concentrations of IL-1b (Fig. 5).
Effects of atrial natriuretic peptide on endothelin-1- and
interleukin 1b-induced phosphorylation of JNK
The activation of JNK was shown to be induced through the
phosphorylation at Thr-183 and Tyr-185 by the dual specific
protein kinase, SAPK/ERK kinase (SEK1), also called MKK4
[41]. As shown in Figure 6A, an immunoblot analysis using an
anti-ACTIVEy-JNK antibody that can recognize the phosphory-
lation at Thr-183 and Tyr-185 of JNK revealed that the phosphor-
ylation of 46 kDa JNK was enhanced by the stimulation of 1028 M
ET-1 or 5000 pg/ml IL-1b. The phosphorylation of 54 kDa JNK
was also detected, although the intensity was much weaker than 46
kDa JNK. This result was compatible with our previous observa-
tion that 46 kDa JNK was preferentially activated by ET-1 when
measured by an in gel kinase assay [19]. Atrial natriuretic peptide
inhibited ET-1-induced phosphorylation of JNK, while ANP
failed to inhibit IL-1b-induced phosphorylation of JNK (Fig. 6A).
The protein content of JNK was not affected by the addition of
these substances (Fig. 6B).
Fig. 4. Dose-dependent effects of interleukin-
1b (IL-1b) on the activities of c-Jun NH2-
terminal kinase (JNK). Cells were exposed to
various concentrations of IL-1b for 15 minutes
and the activities of JNK were measured by the
solid phase kinase assay. A representative
autoradiograph (A) and the relative kinase
activities of JNK (B) are shown. Values are
mean 6 SD (N 5 3 to 5). *P , 0.01 versus
basal.
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Effect of atrial natriuretic peptide on an endothelin-1-induced
increase in intracellular calcium
We have reported that an increase in [Ca21]i is necessary for
ET-1-induced activation of JNK in mesangial cells [19]. Thus, the
inhibitory effect of ANP on ET-1-induced activation of JNK could
be due to the inhibition of the ET-1-induced increase in [Ca21]i.
Although ANP was shown to prevent an increase in [Ca21]i by
angiotensin II in mesangial cells [42], it has been reported that
ANP failed to inhibit ET-1-induced increase in [Ca21]i in cultured
vascular smooth muscle cells [43]. Hence, we next examined the
effect of ANP on the ET-1-induced increase in [Ca21]i in mesan-
gial cells. Typical waveforms obtained from a single mesangial cell
exposed to 1027 M ET-1 with or without pretreatment of 10210 to
1027 M ANP are shown in Figure 7 A-E. The peak concentrations
of calcium are calculated and shown in Figure 7F. Endothelin-1
increased [Ca21]i from 129.9 6 19.2 to 888.5 6 105.7 nM (mean 6
SEM, N 5 16, P , 0.01). Basal calcium levels were not affected by
ANP, while the peak [Ca21]i induced by ET-1 was significantly
attenuated by ANP in concentrations sufficient to inhibit ET-1-
induced activation of JNK.
Effects of atrial natriuretic peptide on endothelin-1- and
interleukin 1b-induced DNA-binding of AP-1
Since the activation of JNK was found to be linked to the
activity of AP-1 [16], it is likely that ANP inhibits ET-1-induced
DNA-binding activity of AP-1. Thus, we examined whether ANP
could inhibit DNA-binding activity of AP-1 enhanced by ET-1 or
IL-1b. Cells were first preincubated with ANP (1027 M) for 10
minutes and then exposed to ET-1 (1028 M) or IL-1b (1000 pg/ml)
for another 60 minutes. As shown in Figure 8, ANP was able to
inhibit ET-1-induced increase in DNA-binding activity of AP-1,
while the IL-1b-induced increase in DNA-binding activity of AP-1
was not affected by ANP.
DISCUSSION
The present study was performed to clarify the mechanisms of
the intracellular interaction between endothelin-1 (ET-1) and
Fig. 5. Effects of atrial natriuretic peptide
(ANP) on interleukin-1b (IL-1b)-induced
activation of c-Jun NH2-terminal kinase (JNK).
Cells were treated with 1027 M ANP for 10
minutes and exposed to 1000 pg/ml or 5000 pg/
ml IL-1b for additional 15 minutes. The
activities of JNK were measured by the solid
phase kinase assay. A representative
autoradiograph (A) and the relative kinase
activities of JNK (B) are shown. Values are
mean 6 SD (N 5 3).
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atrial natriuretic peptide (ANP); the results clearly indicate that
ANP is able to inhibit ET-1-induced activation of JNK through a
cGMP-dependent mechanism. Our data also indicate that ANP is
able to inhibit ET-1-induced increase in intracellular calcium
([Ca21]i) and DNA-binding of AP-1.
Atrial natriuretic peptide has been shown to counteract ET-1-
induced contraction, proliferation and extracellular matrix (ECM)
production in mesangial cells [6–9]. To understand the mecha-
nism of the interaction between these two peptides, it is important
to clarify the effect of ANP on signal transduction systems of
ET-1. Recent studies indicate that the mitogen-activated protein
kinase (MAPK) family plays an important role in various cellular
functions in response to diverse extacellular stimuli, including
vasoconstrictive peptides such as ET-1 and angiotensin II [11–15,
19]. Among the MAPK family, ERK (also known as p44 and p42
MAPK) was shown to be typically activated by various growth
factors, while JNK (also known as stress-activated protein kinase;
SAPK) was found to be activated by inflammatory cytokines and
environmental stress [34–38]. We and others have reported that
ET-1 is able to activate both ERK and JNK in a similar degree
[11, 12, 18, 19], suggesting that both ERK and JNK contribute to
the regulation of the cellular responses to ET-1 in mesangial cells.
Thus, we hypothesized that ANP might counteract the effect of
ET-1 by interfering with these signal transduction systems of
ET-1. The present results and our previous observations [18, 24]
clearly indicate that ANP is able to inhibit ET-1-induced activa-
tion of both ERK and JNK.
The inhibitory effect of ANP on ET-1-induced activation of
JNK shown in the present study is considered to be mediated by
the biological receptors of ANP because of the following reasons.
First, the inhibitory effect of ANP on ET-1-induced activation of
JNK was prevented by HS-142-1, a competitive and selective
antagonist for biological receptors for ANP [31], which could
inhibit ANP-induced cGMP production in mesangial cells [32].
Secondly, C-ANP, an analog specific to clearance receptors for
ANP [44], failed to inhibit ET-1-induced activation of JNK.
Furthermore, the inhibitory effect of ANP on ET-1-induced
activation of JNK was mimicked by 8-Br-cGMP, a cell permeable
analog of cGMP, and SNP, an activator of soluble guanylyl
cyclase. Therefore, the inhibitory effect of ANP on ET-1-induced
activation of JNK is considered to be mediated by an increase in
intracellular cGMP resulted from the activation of the biological
receptor-coupled guanylyl cyclase [33].
Endothelin-1 is known to bind to G protein-coupled receptor
and activate pospholipase Cb (PLCb), leading to an increase in
[Ca21]i and the activation of protein kinase C (PKC) through the
production of inositol 1,4,5-trisphosphate and diacylglycerol, re-
spectively [1–3]. In addition, the activation of protein tyrosine
kinases (PTK) was also found to be involved in the signal
transduction of ET-1 [23, 45, 46]. We have reported that ANP is
able to inhibit ET-1-induced activation of ERK by inhibiting the
activation of PKC [18]. However, the mechanism of the inhibition
of ET-1-induced activation of JNK by ANP should be different
from that of the inhibition of ERK because the activation of PKC
was not involved in ET-1-induced activation of JNK in mesangial
cells [19]. Instead, an increase in [Ca21]i and the activation of
PTK were found to be responsible for the activation of JNK by
ET-1 [15, 19]. In the present study, we demonstrated that ANP
was able to attenuate the ET-1-induced increase in [Ca21]i in
sufficient concentrations to inhibit ET-1-induced activation of
JNK, suggesting that the inhibition of an increase in [Ca21]i could
be a potent mechanism of the inhibitory effect of ANP on the
ET-1-induced activation of JNK. In addition, a novel calcium-
dependent protein-tyrosine kinase (CADTK) has been shown to
transmit Ca21-signals from G protein-coupled receptors to JNK
in rat liver epithelial cells [47]. Thus, ANP may inhibit this
calcium-dependent tyrosine kinase through its Ca21-lowering
effect, although this possibility needs to be clarified further.
In contrast to ET-1-induced activation of JNK, ANP failed to
inhibit the IL-1b-induced activation of JNK in mesangial cells.
Although little information is available on the mechanisms re-
sponsible for the activation of JNK by IL-1b in mesangial cells, the
Fig. 6. Effects of atrial natriuretic peptide
(ANP) on endothelin-1 (ET-1)- and interleukin-
1b (IL-1b)-induced phosphorylation of c-Jun
NH2-terminal kinase (JNK). Cells were
incubated with or without 1027 M ANP for 10
minutes and exposed to 1028 M ET-1 or 5000
pg/ml IL-1b for an additional 15 minutes. Cell
lysates were subjected to SDS-PAGE followed
by immunoblot analysis with anti-ACTIVEy-
JNK antibody (A). The membranes were
reprobed with anti-JNK1 antibody (B).
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present results are consistent with the previous report demon-
strating that cAMP was able to inhibit Ca21-dependent but not
stress-induced activation of JNK in rat liver epithelial cells [48]. In
addition, IL-1b was shown to activate JNK by both PKC- and
PTK-independent mechanisms [39], and it was recently found that
[Ca21]i was not involved in the signaling of IL-1 in mesangial cells
[49]. These results indicate that IL-1b activates JNK by mecha-
nisms different from those of ET-1, and also indicate that the
effect of ANP on JNK might not be general but specific at least to
vasoconstrictive peptides such as ET-1.
We and others have shown that ET-1 enhances DNA-binding
activity of AP-1 composed of c-Jun and c-Fos proteins [19, 23]. In
the present study, we found that ANP was able to inhibit the
ET-1-induced increase in DNA-binding activity of AP-1. This
inhibition of AP-1 activity by ANP might be due to the inhibition
of the production of c-Jun and c-Fos through the inhibition of
ET-1-induced activation of both JNK and ERK. Alternatively, the
inhibition of ET-1-induced activation of JNK by ANP might be
more important. The latter possibility is supported by recent
reports indicating that the phosphorylation of c-Jun protein is
crucially important for AP-1 complex to potentiate its transcrip-
tional activity [50], and that the inhibition of thrombin-induced
cell proliferation and AP-1 activity by cAMP is correlated with a
decrease in JNK activity in vascular smooth muscle cells [17].
Thus, the inhibitory effect of ANP on ET-1-induced AP-1 activity
possibly through the inhibition of the activation of JNK is
considered to be one of the important mechanisms of antiprolif-
erative effect of ANP. Because ANP was shown to inhibit the
proliferation of mesangial cells by inducing TGF-b through
cGMP-dependent mechanism [51], ANP could be considered to
have dual mechanisms for its antiproliferative effect: one is the
inhibition of AP-1 activity shown in the present study and the
other is the induction of TGF-b. A number of genes of ECM
proteins such as type I collagen and fibronectin were shown to
have potential AP-1-binding sites, and these sites were found to be
essential for the regulation of gene expression [52, 53]. Since ANP
has been also reported to inhibit ECM protein production stim-
ulated by thromboxane and ET-1 [8, 9], it can be speculated that
ANP could also counteract ECM protein production by ET-1 by
inhibiting the DNA-binding activity of AP-1.
Glomerular mesangial cells are exposed in vivo to various
vasoactive substances and the functions of mesangial cells are
regulated by a feedback mechanism as well as an interaction of
these substances. For example, ET-1 was shown to down-regulate
its receptors [54] in mesangial cells, while an increase in the
production of ET-1 by ET-1 itself was also found in mesangial
Fig. 7. Effects of atrial natriuretic peptide (ANP) on endothelin-1 (ET-1)-induced increase in intracellular calcium ([Ca21]i). Cells were loaded with
fura-2/AM and [Ca21]i was measured fluorometrically and calculated as described in the Methods section. Fura-2-loaded mesangial cells were treated
with various concentrations of ANP for 10 minutes and then exposed to 1027 M ET-1. The typical [Ca21]i waveforms evoked in a cell exposed to 10
27
M ET-1 (A) and those in a cell pre-treated with 10210 M (B), 1029 M (C), 1028 M (D) or 1027 M (E) ANP prior to the exposure to ET-1 are shown. The
peak [Ca21]i evoked by ET-1 in cells pre-treated with various concentrations of ANP was calculated (F). Data are mean 6 SEM (N 5 8 to 16), *P ,
0.01 versus ET-1 without ANP.
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cells [55, 56], suggesting the existence of a complex positive or
negative feedback system. Although these complex regulations
should be taken into consideration to understand the cellular
response in physiological and pathological conditions, the
crosstalk of the signal transduction system between ET-1 and
ANP at the level of MAPK family shown in the present study and
our previous study [18] may provide one of the important
mechanisms of the interaction between these substances in mes-
angial cells.
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APPENDIX
Abbreviations used in this article are: ANP, atrial natriuretic peptide;
8-Br-cGMP, 8-Bromo-cGMP; [Ca21]i, intracellular calcium; CADTK,
calcium-dependent protein-tyrosine kinase; C-ANP, rat des-[Glu18-
Ser19-Gly20-Leu21-Gly22]ANP4-23-NH2; DTT, dithiothreitol; ERK, ex-
tracellular signal-regulated kinase; ET-1, endothelin-1; FBS, fetal bovine
serum; GST, glutathione-S-transferase; IL-1B, interleukin-1B; JNK, c-Jun
NH2-terminal kinase; KHH, Krebs-Henseleit Hepes buffer; MAPK, mi-
togen-activated protein kinase; PBS, phosphate buffered saline; PLCB,
phospholipase CB; PMSF, phenylmethylsulfonyl fluoride; PTK, protein
tyrosine kinase; SEK1, the specific protein kinase SAPK/ERK kinase;
SNP, sodium nitroprusside; TNF-a, tumor necrosis factor-a.
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